The Effect of Erythropoietin in the Treatment of Scleral Necrosis
Clinical trial NCT05476042 · UNKNOWN
Trial details
- NCT number
- NCT05476042
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-14
- Primary completion
- 2022-11-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.